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REVIEWS AND COMMENTARY • EDITORIAL
When the earth transitioned to an oxygen-containing atmosphere, many bacterial species were killed by 
the free radicals that developed in their cytoplasm. New 
life forms took advantage of this change by evolving to 
use oxygen as the final resting place for electrons involved 
in the Krebs cycle. Animals today rely on getting oxy-
gen into the blood stream and getting carbon dioxide out 
by ventilation through sequentially smaller and smaller 
tubes until diffusion takes over, finally reaching the ter-
minal respiratory bronchiole and its associated alveoli for 
gas exchange. All animals are obligate aerobes. One group 
(1) has estimated that there are 274 to 790 million alveoli 
in the healthy adult lung. In this issue of Radiology, Kim 
et al (2) describe a visualization method to study the in-
visible small airways (seven to 30th generation) that move 
air from the trachea to the peripheral airways and back 
again for normal ventilation.
Enumerating the health, composition, number, and 
location of the small airways is an important goal for 
chest imaging and research. Whereas current thin-section 
chest CT routinely shows sixth-order branching of the 
tracheobronchial tree, unless the airway is diseased or 
plugged, smaller airways from the seventh to 30th gen-
eration are not seen because they are below the resolution 
of current clinical CT hardware. In this issue, Kim et al 
(2) describe a method, named full-scale airway network 
(FAN), to begin to model and study these important struc-
tures. The method is derived from computational fluid dy-
namics (modeling airflow instead of fluid) to achieve an 
idealized representation of the likely number of branching 
elements, their location, and the effective lumen size of all 
the bronchial structures to the level of the alveolus. Lin 
and colleagues (3) used a similar approach to show particle 
depositions within the lung for determining the optimal 
sizes for drug therapy aerosols. By using the FAN modeling 
approach, we now have a tool to probe the role of disease 
on the lung microstructure in health and disease. We feel 
that the FAN model is an important advance in respiratory 
research.
Diseases of the lung are important for world health. 
Chronic obstructive pulmonary disease (COPD) will be 
the third most important cause of mortality in the world 
by 2020 (4). The inability to breathe is life threatening, 
and difficulty breathing (with or without supplemen-
tal oxygen) adds significant morbidity to the activities 
of daily life. How should we study the changes in the 
lung that occur with smoking and air pollution? The 
role of inhaled microparticulates from air pollution and 
cooking indoors by using biofuels has been shown to 
adversely affect lung function (5).
It is reasonable to ask what research questions are 
now answerable with the FAN method. Whereas there 
are many possible answers to this question, it is most 
likely that the area that will show the most activity re-
volves around the issue of how particulates affect small 
airway disease. How air pollution and occupational 
lung diseases impact the lumen of the seventh to 30th 
generation bronchi is going to be the major advance of 
this method. With the many microparticulates from air 
pollution becoming a larger issue in metropolitan areas, 
this tool has the opportunity to help us determine its 
importance on lung function at a personalized level. For 
the workers who have occupational exposure to silica 
and coal dusts this tool may also be useful in showing 
the individualized burden of disease. The use of fractals, 
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a mathematical method for determining the branching pat-
tern of structures, directly enumerates the simplification of 
airways in COPD (6). It will be of interest to discover how 
the FAN method helps to elucidate the number of airways 
in healthy adults and their fractal dimension. It is likely that 
these values will change in health, disease, and with aging. 
It is easy to imagine that pediatric and adult nomograms for 
airway numbers and fractal dimension will become another 
metric by which to measure lung maturation and health (7). 
Enumeration of the change in number of airways to docu-
ment therapeutic response or disease progression could also 
become important.
Recently, micro-CT has been used for the ex vivo evaluation 
of inflated frozen human lung specimens. This approach allows 
for the visualization of the three-dimensional structure of the lung 
down to the level of the terminal bronchioles. The lack of fixative 
also enables subsequent comparison with the cellular matrix and 
gene expression changes that occur with disease. By using such 
micro-CT methods, Tang et al (7) also showed in animal studies 
that air pollution adversely affects fetal lung growth.
The use of fractals, a mathematical method for determin-
ing the branching pattern of structures, directly enumerates 
the simplification of airways in COPD and pulmonary arter-
ies in pulmonary hypertension (6,8). It will be of interest to 
discover how the FAN method helps to further elucidate the 
number of airways in healthy adults and their fractal dimen-
sion. It is likely that these values will change in health, dis-
ease, and with aging. It is easy to imagine that pediatric and 
adult nomograms for airway numbers and fractal dimension 
will become another metric by which to measure lung matu-
ration and health. Enumeration of the change in number of 
airways to document therapeutic response or disease progres-
sion could also become important.
The limitations of the modeling method presented by Kim 
et al (2) are still unknown because their method was only dem-
onstrated in nine patients with COPD. However, at a mini-
mum there needs to be validation of this approach with ex vivo 
histologic examination and/or micro-CT imaging in healthy 
and diseased lungs. The model relies on the expected flow of gas 
to a terminal location (the alveoli) but this does not account for 
remodeling of the airway from disease, and so the mathematics 
can only show an average lumen size, average length of a bron-
chiole, average angle of a bifurcation, and the likely location 
within the lung. There remain other questions as well: Does the 
model account for tapering from the beginning of a segment to 
the branch point? Does the model identify collapsibility of the 
airway at expiration? What is the influence of the use of −950 
HU as the cutoff for emphysema when the examination was 
not performed at full inspiration (total lung capacity)? And, 
finally, will the computation of the model change when tissue 
density is calculated at 37°C instead of 0°C? The good news 
here is that all of these reservations regarding the quality of 
the model are testable and the FAN model can be modified to 
more closely approximate the truth.
With the introduction of computational methods and ad-
vanced programming, imaging science is leading medicine to 
ways of understanding the body’s response to disease. The 
sharing of methods so that others can reproduce published 
results is, however, potentially problematic if the code is not 
published. For the authors, publishing the code means that it 
can no longer be patent protected, limiting its potential future 
commercial value. Thus, there is a tug-of-war between publish-
ing one’s study with access to the code that can be used by 
others to replicate the results and the desire to have a commer-
cial product. Importantly, the modeling software developed by 
Kim et al (2) will be made available to other potential users so 
they can build on their results.
The ability to study a relatively unknown region of the body 
is exciting. This is unexplored territory for scientific researchers 
and should promise to be of more than just academic interest. 
For example, if we can learn how to limit or prevent lung de-
struction from air pollution, cannabis, and tobacco smoke and/
or vaping, this could serve to substantially improve the lives of 
many who are exposed to these materials. For those with asthma, 
learning how to modify the response of the small airways to 
antigens will be key in helping their pulmonary function. We 
know that lung function decreases as we age (9). Perhaps the 
FAN method will show that remodeling and simplification of 
the bronchial structures helps to explain this fact. Knowing what 
happens to the airways will allow investigators to research meth-
ods that can act to keep the lungs youthful. We look forward to 
future innovations on the basis of modeling of the small airways.
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